The Brussels Call to Action brings together key priorities for improving liver cancer prevention, care and outcomes. We invite individuals and organisations across the liver cancer community and beyond to read the Call to Action and add their support.
Once you have read the Call to Action, add your name or organisation in support.
Prioritise liver cancer
Prioritise liver cancer within national and global health agendas, cancer and NCD strategies, liver health programmes, universal health coverage and health financing.
Strengthen data and measurement
Strengthen data and measurement to better understand the burden of liver cancer, inequalities, outcomes and access to prevention and care.
Ensure affordable and equitable access
Ensure affordable and equitable access to prevention and care, from surveillance and early diagnosis through multidisciplinary treatment, supportive care and palliative care.
Put patients at the centre
Put patients at the centre, with meaningful involvement in policy, research and service design, alongside stronger health literacy, patient navigation and action against stigma.
Accelerate research and responsible innovation
Accelerate research and responsible innovation, including wider participation in clinical research and appropriate use of digital health and AI to improve access, quality and efficiency.
Mobilise political commitment and sustainable financing
Mobilise political commitment and sustainable financing to turn international commitments into measurable action and expand access to essential liver cancer interventions.
We are proud to launch the Brussels Call to Action on Liver Cancer, a joint advocacy statement emerging from the ILCA Annual Conference 2026 in Brussels. The Call to Action brings together the global liver cancer community around a shared commitment to elevate liver cancer on the global health agenda and accelerate action on prevention, early detection, equitable access to care, research, and innovation.
Liver cancer remains one of the leading causes of cancer-related deaths worldwide, yet many cases are preventable, and outcomes can be improved through timely diagnosis and access to effective treatment. The Brussels Call to Action outlines a clear roadmap for governments, health authorities, policymakers, and stakeholders to address this growing public health challenge.
Throughout Liver Cancer Awareness Month, ILCA will continue to shine a light on the urgent need for greater awareness, stronger political commitment, and improved access to prevention, diagnosis, treatment, and care for people affected by liver cancer worldwide.
The Brussels Call to Action on Liver Cancer was developed through the commitment and collaboration of the global liver cancer community.
ILCA sincerely thanks Dr Mariam Jashi, Chief Executive Officer of the Global Sepsis Alliance and Global Board Member of the UNITE Parliamentarians Network, for her invaluable support in shaping the concept, development, and advocacy framework of the Brussels Call to Action on Liver Cancer. Her expertise, guidance, and active engagement were instrumental in advancing this initiative.
ILCA also warmly acknowledges the International Liver Cancer Movement (ILCM) for its partnership in establishing the initiative, shaping its concept, supporting the advocacy meeting, and leading a dedicated workshop.
Have you read the Brussels Call to Action and support its ambitions? Join the individuals and organisations adding their voice to this collective call for action on liver cancer.